adamantane has been researched along with sto 609 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Derkach, VA; Dwarakanath, D; Fortin, DA; Nygaard, S; Pierre, P; Soderling, TR; Srivastava, T | 1 |
1 other study(ies) available for adamantane and sto 609
| Article | Year |
|---|---|
Brain-derived neurotrophic factor activation of CaM-kinase kinase via transient receptor potential canonical channels induces the translation and synaptic incorporation of GluA1-containing calcium-permeable AMPA receptors.
Topics: 2-Amino-5-phosphonovalerate; Adamantane; Animals; Benzimidazoles; Brain-Derived Neurotrophic Factor; Calcium Channel Blockers; Calcium-Calmodulin-Dependent Protein Kinase Kinase; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Female; Gene Knockdown Techniques; Hippocampus; Imidazoles; Male; Miniature Postsynaptic Potentials; Naphthalimides; Neurons; Primary Cell Culture; Rats; Rats, Sprague-Dawley; Receptors, AMPA; RNA, Small Interfering; TOR Serine-Threonine Kinases; TRPC Cation Channels | 2012 |